Subtopic Deep Dive

Middle Meningeal Artery Embolization for Hematoma
Research Guide

What is Middle Meningeal Artery Embolization for Hematoma?

Middle meningeal artery embolization is an endovascular procedure targeting the middle meningeal artery to treat chronic subdural hematoma by reducing neovascularization and hematoma recurrence.

Research shows MMA embolization achieves success rates of 70-90% in preventing CSDH recurrence compared to 20-30% with surgery alone (Ban et al., 2017; Link et al., 2018). Over 40 studies since 2000 evaluate its efficacy, with meta-analyses confirming lower reoperation rates (Srivatsan et al., 2018; Ironside et al., 2021). It serves as an adjunct or primary therapy for high-risk patients.

15
Curated Papers
3
Key Challenges

Why It Matters

MMA embolization reduces hospital stays and costs for elderly patients with comorbidities, avoiding craniotomy risks (Kan et al., 2020). Feghali et al. (2020) highlight its role in managing recurrent CSDH, common in anticoagulated populations. Link et al. (2018) report 82% success in 60 cases, enabling outpatient management and improving outcomes in frail cohorts.

Key Research Challenges

Recurrence Prediction

Identifying patients at high risk for CSDH recurrence post-embolization remains difficult due to variable hematoma membranes. Ban et al. (2017) found 18% failure rate linked to incomplete embolization. Meta-analyses show imaging biomarkers needed for better stratification (Ironside et al., 2021).

Embolization Technique Variability

Differences in embolic agents like PVA vs. Onyx affect occlusion rates and complications. Kan et al. (2020) report multi-center variations in approach leading to 6% procedural risks. Standardization lacks consensus across studies (Srivatsan et al., 2018).

Long-term Safety Data

Limited follow-up beyond 6 months raises concerns for cranial nerve ischemia or rebleeding. Mandai et al. (2000) noted success in refractory cases but called for randomized trials. Recent series lack 2-year outcomes (Link et al., 2018).

Essential Papers

1.

Middle Meningeal Artery Embolization for Chronic Subdural Hematoma

Seung Pil Ban, Gyojun Hwang, Hyoung Soo Byoun et al. · 2017 · Radiology · 399 citations

Purpose To evaluate the effect of middle meningeal artery (MMA) embolization on chronic subdural hematoma (CSDH) and compare the treatment outcomes of MMA embolization and conventional treatment. M...

2.

Updates in Chronic Subdural Hematoma: Epidemiology, Etiology, Pathogenesis, Treatment, and Outcome

James Feghali, Wuyang Yang, Judy Huang · 2020 · World Neurosurgery · 323 citations

3.

Carotid-cavernous fistulas

Jason A. Ellis, Hannah E. Goldstein, E. Sander Connolly et al. · 2012 · Neurosurgical FOCUS · 306 citations

Carotid-cavernous fistulas (CCFs) are vascular shunts allowing blood to flow from the carotid artery into the cavernous sinus. The characteristic clinical features seen in patients with CCFs are th...

4.

Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A Series of 60 Cases

Thomas W. Link, Srikanth Boddu, Stephanie M Paine et al. · 2018 · Neurosurgery · 246 citations

Abstract BACKGROUND Chronic subdural hematoma (SDH) is a particularly challenging pathology due to high recurrence rates (2%-37%) and complex medical comorbidities that tend to afflict the patient ...

5.

Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A Multi-Center Experience of 154 Consecutive Embolizations

Peter Kan, Georgios Α. Maragkos, Aditya Srivatsan et al. · 2020 · Neurosurgery · 234 citations

Abstract BACKGROUND Middle meningeal artery (MMA) embolization has emerged as a promising treatment for chronic subdural hematoma (cSDH). OBJECTIVE To determine the safety and efficacy of MMA embol...

6.

Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Meta-Analysis and Systematic Review

Aditya Srivatsan, Alina Mohanty, Fábio A. Nascimento et al. · 2018 · World Neurosurgery · 222 citations

7.

Middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis

Natasha Ironside, Candice Nguyen, Quan Do et al. · 2021 · Journal of NeuroInterventional Surgery · 218 citations

Middle meningeal artery (MMA) embolization has been proposed as a minimally invasive treatment for chronic subdural hematoma (cSDH). The aim of this systematic review and meta-analysis is to compar...

Reading Guide

Foundational Papers

Start with Mandai et al. (2000) for first refractory case success, Yadav et al. (2014) for CSDH epidemiology, and Hashimoto et al. (2013) for early efficacy data to grasp origins.

Recent Advances

Prioritize Ban et al. (2017), Link et al. (2018), Kan et al. (2020), and Ironside et al. (2021) meta-analysis for modern outcomes and multi-center evidence.

Core Methods

Core techniques: transfemoral access, particle/coil embolization under fluoroscopy, confirmed by angiography; adjunct to burr-hole drainage (Ban et al., 2017; Link et al., 2018).

How PapersFlow Helps You Research Middle Meningeal Artery Embolization for Hematoma

Discover & Search

Research Agent uses searchPapers and citationGraph on 'middle meningeal artery embolization chronic subdural hematoma' to map 250+ papers, starting from Ban et al. (2017, 399 citations) as the hub with forward/backward citations to meta-analyses like Ironside et al. (2021). exaSearch uncovers procedural variants; findSimilarPapers links foundational Mandai et al. (2000) to recent Kan et al. (2020).

Analyze & Verify

Analysis Agent applies readPaperContent to extract success rates from Link et al. (2018), then verifyResponse with CoVe against meta-data from Srivatsan et al. (2018) for 82% vs. 90% claims. runPythonAnalysis computes pooled recurrence odds ratios via pandas on exported CSV from 10 papers; GRADE grading scores Ban et al. (2017) as high-quality evidence.

Synthesize & Write

Synthesis Agent detects gaps like long-term RCTs via contradiction flagging between Mandai et al. (2000) and Ironside et al. (2021); Writing Agent uses latexEditText for protocol drafts, latexSyncCitations to integrate 20 references, and latexCompile for camera-ready reviews. exportMermaid visualizes embolization vs. surgery outcome flows.

Use Cases

"Extract and plot recurrence rates from MMA embolization meta-analyses"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas/matplotlib on Ban 2017, Srivatsan 2018, Ironside 2021 data) → matplotlib plot of ORs with 95% CIs.

"Draft LaTeX review comparing MMAE to craniotomy for CSDH"

Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Kan 2020, Link 2018) + latexCompile → PDF with tables/figures.

"Find code for MMA embolization simulation models"

Research Agent → paperExtractUrls (Feghali 2020) → Code Discovery → paperFindGithubRepo → githubRepoInspect → forked CFD model repo for hematoma flow.

Automated Workflows

Deep Research workflow conducts systematic review: searchPapers (50+ MMAE papers) → citationGraph → DeepScan (7-step GRADE/CoVe on Ban/Link/Kan) → structured report with meta-stats. Theorizer generates hypotheses on embolic agent efficacy from Mandai (2000) to Ironside (2021) contradictions. DeepScan verifies recurrence claims across multi-center data (Kan et al., 2020).

Frequently Asked Questions

What defines middle meningeal artery embolization for hematoma?

MMA embolization occludes the middle meningeal artery to starve CSDH membranes of blood supply, reducing recurrence (Ban et al., 2017).

What are key methods in MMA embolization?

Transarterial access uses PVA particles, Onyx, or coils; success confirmed by DSA (Kan et al., 2020; Link et al., 2018).

What are seminal papers?

Ban et al. (2017, 399 citations) first compared MMAE to surgery; Mandai et al. (2000, 191 citations) pioneered refractory cases (Srivatsan et al., 2018 meta-analysis).

What open problems exist?

Randomized trials vs. surgery needed; long-term ischemia risks and optimal agents unresolved (Ironside et al., 2021; Feghali et al., 2020).

Research Neurosurgical Procedures and Complications with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Middle Meningeal Artery Embolization for Hematoma with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers